The Cyprotex team look forward to meeting you at booth #4222
Cyprotex (www.cyprotex.com) was founded in 1999 and specialises in in vitro and in silico ADME-Tox. The company has sites in the UK and the US. In 2016, Cyprotex was acquired by Evotec AG (www.evotec.com). As a whole, the Group offer integrated and stand-alone drug discovery capabilities as well as full CMC and IND-enabling services, allowing the company to provide expert support across the value chain from early discovery through to preclinical development and beyond.